AR039617A1 - Evaluacion del cancer colorectal - Google Patents

Evaluacion del cancer colorectal

Info

Publication number
AR039617A1
AR039617A1 ARP030101130A ARP030101130A AR039617A1 AR 039617 A1 AR039617 A1 AR 039617A1 AR P030101130 A ARP030101130 A AR P030101130A AR P030101130 A ARP030101130 A AR P030101130A AR 039617 A1 AR039617 A1 AR 039617A1
Authority
AR
Argentina
Prior art keywords
colorectal cancer
cancer assessment
cancer
assessment
microordinations
Prior art date
Application number
ARP030101130A
Other languages
English (en)
Original Assignee
Ortho Clinical Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Clinical Diagnostics Inc filed Critical Ortho Clinical Diagnostics Inc
Publication of AR039617A1 publication Critical patent/AR039617A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Un método para evaluar la presencia o la ausencia de cáncer colorectal o la probable condición de una persona que se considera con cáncer colorectal se conduce por análisis de la expresión de un grupo de genes. Los perfiles de expresión génica en una variedad de medios como microordinamientos se incluyen como kits que los contienen. También se hace referencia a porfolio, kit y artículos para diagnosticar el cáncer.
ARP030101130A 2002-03-29 2003-04-01 Evaluacion del cancer colorectal AR039617A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36879802P 2002-03-29 2002-03-29

Publications (1)

Publication Number Publication Date
AR039617A1 true AR039617A1 (es) 2005-03-02

Family

ID=28675541

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030101130A AR039617A1 (es) 2002-03-29 2003-04-01 Evaluacion del cancer colorectal

Country Status (10)

Country Link
US (1) US20030186302A1 (es)
EP (1) EP1355149A3 (es)
JP (2) JP4354724B2 (es)
KR (1) KR100991673B1 (es)
CN (2) CN101603092B (es)
AR (1) AR039617A1 (es)
AU (1) AU2003203562A1 (es)
BR (1) BR0303091A (es)
CA (1) CA2422298C (es)
MX (1) MXPA03002866A (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4517189B2 (ja) * 2003-05-19 2010-08-04 生化学工業株式会社 糖ヌクレオチド運搬作用を有するタンパク質、組織の癌化の検出方法
US20080058432A1 (en) * 2006-03-03 2008-03-06 Yixin Wang Molecular assay to predict recurrence of Duke's B colon cancer
ES2332557B1 (es) * 2007-12-04 2011-02-02 Universidad Autonoma De Madrid Huella genomica para el pronostico de la evolucion de adenocarcinoma colorectal.
MX2012003198A (es) * 2009-10-23 2012-06-12 Millennium Pharm Inc Moleculas de anticuerpo anti-gcc y composiciones y metodos relacionados.
US20120172244A1 (en) 2010-12-20 2012-07-05 Steven Buechler Biomarkers and uses thereof in prognosis and treatment strategies for right-side colon cancer disease and left-side colon cancer disease
EP2655663A4 (en) * 2010-12-20 2015-01-28 Univ Notre Dame Du Lac BIOMARKERS AND THEIR USE FOR PROGNOSIS AND TREATMENT STRATEGIES FOR RIGHT-SIDED AND LEFT-SIDE COLON CARCINOMA
CN102586420B (zh) * 2011-12-27 2014-10-22 盛司潼 一种检测乳腺癌易感基因的方法及试剂盒
CN102586423B (zh) * 2011-12-27 2015-01-07 盛司潼 一种检测结直肠癌易感基因的方法及试剂盒
CN106367527A (zh) * 2016-11-17 2017-02-01 苏州大学附属第二医院 直肠癌放化疗疗效相关靶基因的鉴定
CN112831563A (zh) * 2021-02-08 2021-05-25 复旦大学附属肿瘤医院 一种遗传性结直肠癌的检测panel及检测试剂盒

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5700637A (en) * 1988-05-03 1997-12-23 Isis Innovation Limited Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays
GB8822228D0 (en) * 1988-09-21 1988-10-26 Southern E M Support-bound oligonucleotides
US5527681A (en) * 1989-06-07 1996-06-18 Affymax Technologies N.V. Immobilized molecular synthesis of systematically substituted compounds
US5242974A (en) * 1991-11-22 1993-09-07 Affymax Technologies N.V. Polymer reversal on solid surfaces
US5143854A (en) * 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
DE3924454A1 (de) * 1989-07-24 1991-02-07 Cornelis P Prof Dr Hollenberg Die anwendung von dna und dna-technologie fuer die konstruktion von netzwerken zur verwendung in der chip-konstruktion und chip-produktion (dna chips)
IL103674A0 (en) * 1991-11-19 1993-04-04 Houston Advanced Res Center Method and apparatus for molecule detection
US5412087A (en) * 1992-04-24 1995-05-02 Affymax Technologies N.V. Spatially-addressable immobilization of oligonucleotides and other biological polymers on surfaces
US5384261A (en) * 1991-11-22 1995-01-24 Affymax Technologies N.V. Very large scale immobilized polymer synthesis using mechanically directed flow paths
US5554501A (en) * 1992-10-29 1996-09-10 Beckman Instruments, Inc. Biopolymer synthesis using surface activated biaxially oriented polypropylene
US5472672A (en) * 1993-10-22 1995-12-05 The Board Of Trustees Of The Leland Stanford Junior University Apparatus and method for polymer synthesis using arrays
US5429807A (en) * 1993-10-28 1995-07-04 Beckman Instruments, Inc. Method and apparatus for creating biopolymer arrays on a solid support surface
US5571639A (en) * 1994-05-24 1996-11-05 Affymax Technologies N.V. Computer-aided engineering system for design of sequence arrays and lithographic masks
US5556752A (en) * 1994-10-24 1996-09-17 Affymetrix, Inc. Surface-bound, unimolecular, double-stranded DNA
US6350576B1 (en) * 1994-12-20 2002-02-26 Cold Spring Harbor Laboratory Cancer detection probes
US5599695A (en) * 1995-02-27 1997-02-04 Affymetrix, Inc. Printing molecular library arrays using deprotection agents solely in the vapor phase
US5624711A (en) * 1995-04-27 1997-04-29 Affymax Technologies, N.V. Derivatization of solid supports and methods for oligomer synthesis
US5545531A (en) * 1995-06-07 1996-08-13 Affymax Technologies N.V. Methods for making a device for concurrently processing multiple biological chip assays
US5658734A (en) * 1995-10-17 1997-08-19 International Business Machines Corporation Process for synthesizing chemical compounds
US6275814B1 (en) * 1996-11-27 2001-08-14 Investment Strategies Network Investment portfolio selection system and method
US6003018A (en) * 1998-03-27 1999-12-14 Michaud Partners Llp Portfolio optimization by means of resampled efficient frontiers
US6218114B1 (en) * 1998-03-27 2001-04-17 Academia Sinica Methods for detecting differentially expressed genes
US6004755A (en) * 1998-04-07 1999-12-21 Incyte Pharmaceuticals, Inc. Quantitative microarray hybridizaton assays
US6218122B1 (en) * 1998-06-19 2001-04-17 Rosetta Inpharmatics, Inc. Methods of monitoring disease states and therapies using gene expression profiles
WO2000012702A2 (en) * 1998-08-31 2000-03-09 Bayer Corporation Human genes differentially expressed in colorectal cancer
US6175824B1 (en) * 1999-07-14 2001-01-16 Chi Research, Inc. Method and apparatus for choosing a stock portfolio, based on patent indicators
KR20020092891A (ko) * 1999-07-15 2002-12-12 리서치 디벨럽먼트 파운데이션 코르티코트로핀 분비 인자 수용체 2 결핍 마우스 및 이의용도
US6271002B1 (en) * 1999-10-04 2001-08-07 Rosetta Inpharmatics, Inc. RNA amplification method

Also Published As

Publication number Publication date
JP2003325190A (ja) 2003-11-18
MXPA03002866A (es) 2004-08-11
BR0303091A (pt) 2004-02-17
US20030186302A1 (en) 2003-10-02
CA2422298C (en) 2013-07-30
EP1355149A2 (en) 2003-10-22
CA2422298A1 (en) 2003-09-29
CN100516233C (zh) 2009-07-22
JP2009153522A (ja) 2009-07-16
KR20030078802A (ko) 2003-10-08
CN1495273A (zh) 2004-05-12
EP1355149A3 (en) 2004-08-25
CN101603092B (zh) 2012-11-07
JP4354724B2 (ja) 2009-10-28
CN101603092A (zh) 2009-12-16
KR100991673B1 (ko) 2010-11-04
AU2003203562A1 (en) 2003-10-23

Similar Documents

Publication Publication Date Title
ES2570359T3 (es) Regiones ultraconservadas que codifican ARNnc
ES2634546T3 (es) Uso de células madre mesenquimales modificadas genéticamente para expresar un gen suicida para tratar un cáncer
ECSP17025787A (es) Uso de paneles de genes mutantes de fgfr en la identificación de pacientes con cáncer que responderán al tratamiento con un inhibidor de fgfr
AR039211A1 (es) Evaluacion del cancer colorectal
AR039210A1 (es) Panel de diagnostico del cancer
AR031455A1 (es) Metodo para determinar un regimen quimioterapeutico basado en la expresion de ercc1
AR039617A1 (es) Evaluacion del cancer colorectal
WO2006138275A3 (en) Compositions and methods for treating and diagnosing cancer
AR043808A1 (es) Pronostico de cancer colorrectal
MX2007004176A (es) B7-h1 y metodos de diagnosis, prognosis, y tratamiento de cancer.
ATE539170T1 (de) Abschätzung und verringerung des risikos von graft-versus-host-reaktion
TW200600785A (en) Method for diagnosing non-small cell lung cancer
DE60235005D1 (de) Nachweis der instabilität von mikrosatelliten und
CO2019003713A2 (es) Metodo y sistema para caracterizaciones de panel
WO2008103971A3 (en) Prostate cancer survival and recurrence
DE602005024964D1 (de) Verfahren zur beurteilung der malignität einer säuger-krebszelle
ATE531529T1 (de) Wertdokument, herstellung und prüfung von wertdokumenten
MX2019000353A (es) Andamios de biomatriz para usarse en el diagnóstico y modelado del cáncer.
ATE426162T1 (de) Verfahren zum untersuchen von kírperflussikeiten auf krebszellen sowie entsprechende analysekits
BRPI0403290A (pt) Prognósticos para câncer de mama
ES2721477T3 (es) Materiales y métodos para evaluar la progresión del cáncer de próstata
CL2021000251A1 (es) Métodos de identificación de pacientes con posibilidad de beneficiarse de un tratamiento con un inhibidor de la telomerasa
DE10345021A1 (de) Verfahren zur nichtinvasiven Früherkennung von Dickdarmkrebs und/oder Darmkrebsvorläuferzellen
DE602004027086D1 (de) Klassifizierung von kolonkrebs
WO2005054507A3 (en) Genes associated with colorectal cancer

Legal Events

Date Code Title Description
FC Refusal